Literature DB >> 5337858

Reticuloendothelial system phagocytic function in patients with Hodgkin's disease.

J N Sheagren, J B Block, S M Wolff.   

Abstract

Phagocytic function of the reticuloendothelial system as measured by the clearance of (125)I-labeled aggregated human serum albumin (AA) was studied in patients with Hodgkin's disease. Each more advanced stage of the disease was associated with more rapid clearance of the AA. Production of remission by radiation therapy or by chemotherapy was associated in some patients with slowing of the clearance rate, whereas relapse seemed to be associated with acceleration. Thus, impaired phagocytosis cannot be implicated in the several defects in immunity known to be present in Hodgkin's disease. Furthermore, determination of the clearance rate of AA in patients with Hodgkin's disease may have clinical usefulness as another indicator of extent or activity of disease.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5337858      PMCID: PMC297087          DOI: 10.1172/JCI105585

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  STUDIES OF THE RETICULOENDOTHELIAL SYSTEM (RES). 3. BLOCKADE OF THE RES IN MAN.

Authors:  H N WAGNER; M IIO
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  LYMPHOCYTOPENIA IN HODGKIN'S DISEASE.

Authors:  A C AISENBERG
Journal:  Blood       Date:  1965-06       Impact factor: 22.113

3.  ENHANCED RETICULOENDOTHELIAL PHAGOCYTIC ACTIVITY IN MYELOPROLIFERATIVE DISEASES.

Authors:  R E BASES; I H KRAKOFF
Journal:  J Reticuloendothel Soc       Date:  1965-05

4.  Susceptibility of mice to pneumococcal infection after modification of the reticuloendothelial system with simple lipids.

Authors:  G N COOPER; A E STUART
Journal:  J Pathol Bacteriol       Date:  1962-01

5.  Antibody response in hematologic patients.

Authors:  S SASLAW; H N CARLISLE; B BOURONCLE
Journal:  Proc Soc Exp Biol Med       Date:  1961-03

6.  Hodgkin's disease and immunity.

Authors:  W W SCHIER; A ROTH; G OSTROFF; M H SCHRIFT
Journal:  Am J Med       Date:  1956-01       Impact factor: 4.965

7.  Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.

Authors:  M W Chase
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

8.  Se methionine as a diagnostic agent in malignant lymphoma.

Authors:  N E Herrera; R Gonzalez; R D Schwartz; A M Diggs; J Belsky
Journal:  J Nucl Med       Date:  1965-11       Impact factor: 10.057

9.  Circulating antibodies in reticuloses.

Authors:  M BARR; G H FAIRLEY
Journal:  Lancet       Date:  1961-06-17       Impact factor: 79.321

10.  Reticular tumours in mice subjected to prolonged antigenic stimulation.

Authors:  D METCALF
Journal:  Br J Cancer       Date:  1961-12       Impact factor: 7.640

View more
  17 in total

1.  [Sturcture and function of the mononuclear phagocytic system (MPS) in chronic rhinosinusitis. A light and electron microscopic investigation (author's transl)].

Authors:  K W Albegger
Journal:  Arch Otorhinolaryngol       Date:  1976-08-31

2.  Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.

Authors:  M de Sousa; A Smithyman; C Tan
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

3.  Immune responsiveness in Hodgkin's disease.

Authors:  P M Denton
Journal:  Br J Cancer Suppl       Date:  1973-08

4.  The control of cancer spread by the reticuloendothelial system.

Authors:  C J Magarey
Journal:  Ann R Coll Surg Engl       Date:  1972-04       Impact factor: 1.891

5.  Decreased tuftsin concentrations in patients who have undergone splenectomy.

Authors:  Z Spirer; V Zakuth; S Diamant; W Mondorf; T Stefanescu; Y Stabinsky; M Fridkin
Journal:  Br Med J       Date:  1977-12-17

Review 6.  Disordered function of mononuclear phagocytes in malignant disease.

Authors:  R J Sokol; G Hudson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

7.  Correlation between immune complexes and prognostic factors in Hodgkin's disease.

Authors:  P L Amlot; B Pussell; J M Slaney; B D Williams
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

Review 8.  Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.

Authors:  M Fridkin; P Gottlieb
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

9.  Relationship between reticuloendothelial systems' FDG uptake level and clinicopathological features in patient with invasive ductal breast cancer.

Authors:  Ertan Şahin; Umut Elboğa
Journal:  Radiol Med       Date:  2017-06-09       Impact factor: 3.469

10.  Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production.

Authors:  J Herman; M C Kew; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.